bluebird bio, Inc. (BLUE)

Oncology Corporate Profile

Stock Performance

92.5000
-0.7500

HQ Location

150 Second Street, Third Floor
Cambridge, MA 2141

Company Description

With its lentiviral-based gene therapies, T cell immunotherapy expertise and gene editing capabilities, bluebird bio has built an integrated product platform with broad potential application to severe genetic diseases and cancer.

Website: https://www.bluebirdbio.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
bb2121anti-BCMA CAR T cell therapyMultiple MyelomaI

View additional information on product candidates here »

Source: https://www.bluebirdbio.com/

Recent News Headlines

8/18/2017 06:17 am

8/18/2017 06:17 am

8/18/2017 06:17 am

8/18/2017 06:17 am

8/18/2017 06:17 am

8/9/2017 06:17 am

8/9/2017 06:17 am

8/9/2017 06:17 am

8/9/2017 06:17 am

8/9/2017 06:17 am

8/7/2017 12:17 pm

8/3/2017 12:18 am

8/3/2017 12:18 am

8/3/2017 12:18 am

8/3/2017 12:18 am

7/25/2017 12:17 pm

7/25/2017 12:17 pm

7/25/2017 12:17 pm

7/25/2017 12:17 pm

7/25/2017 12:17 pm

7/14/2017 06:17 am

7/13/2017 06:17 am

7/12/2017 12:17 pm

7/9/2017 06:17 am

7/5/2017 06:17 pm